Regulation

Canada Takes a Science-Based Approach to Assessing Asbestos in Drinking Water

()
It also acknowledges, in line with the World Health Organization’s (WHO) previous position, that “there is no consistent, convincing evidence that oral exposure to asbestos causes adverse effects in humans and animals.” The document also cites research findings from animal and human studies, indicating that “more than 99% of all ingested asbestos fibres pass through the digestive system and are excreted within 48 hours.” Furthermore, “the few fibres that do cross the intestinal barrier are generally less than 1 µm in length, a size that is not considered to be carcinogenic.”

In the early months of 2026, Health Canada (HC), in collaboration with the Canadian Federal-Provincial-Territorial Committee on Drinking Water (CDW), initiated a consultation process to prepare for the publication of a document entitled “Draft Guidance on Asbestos in Drinking Water”. The document focuses on the presence of asbestos in drinking water, potential exposure pathways, and the possible impacts on human health.

May be a graphic of text

The draft document adopts a relatively balanced and scientifically cautious approach. From the outset, it highlights fundamental differences relating to fibre dimensions, exposure levels, and fibre durability. It also acknowledges, in line with the World Health Organization’s (WHO) previous position, that “there is no consistent, convincing evidence that oral exposure to asbestos causes adverse effects in humans and animals.” The document also cites research findings from animal and human studies, indicating that “more than 99% of all ingested asbestos fibres pass through the digestive system and are excreted within 48 hours.” Furthermore, “the few fibres that do cross the intestinal barrier are generally less than 1 µm in length, a size that is not considered to be carcinogenic.” These findings highlight the importance of considering fibre characteristics, exposure levels, and specific exposure pathways when assessing potential health risks associated with asbestos. In particular, inhalation and oral exposure involve different mechanisms of interaction with the human body. Therefore, the same risk assessment approach should not automatically be applied to both exposure pathways. The draft guidance further emphasizes that conclusions regarding health effects should be based on a comprehensive review of available scientific evidence, including human studies, experimental animal research, and data concerning the absorption, transportation, and elimination of asbestos fibres within the body. This approach is important for distinguishing between potential hazards and actual risks, while avoiding premature conclusions without fully considering the characteristics of each exposure pathway.

May be an image of body of water

Following its publication, the draft document received mixed reactions, particularly from organizations and individuals involved in anti-asbestos advocacy. Some expressed strong disagreement with its findings, especially the statement that there is no consistent and convincing evidence demonstrating adverse health effects from oral exposure to asbestos. These reactions indicate that asbestos in drinking water remains an issue requiring further research and discussion, involving regulatory authorities, the scientific community, and other relevant stakeholders.

Interested parties were invited to submit comments on the draft document by mid-April 2026. Following the consultation period, Health Canada will review the feedback received before finalizing and issuing the official guidance. This process is expected to contribute to a clearer scientific basis for assessing and managing asbestos in drinking water, while providing additional references for other countries developing policies on water quality and public health. Canada Takes a Science-Based Approach to Assessing Asbestos in Drinking WaterThe issue may also attract further attention in international discussions on asbestos management, particularly in the lead-up to the 13th Conference of the Parties to the Rotterdam Convention (COP-13), scheduled to take place in Panama in 2027. As countries continue to adopt different approaches to asbestos management, updated scientific research and assessments of the various exposure pathways will play an important role in policymaking, helping ensure that regulatory decisions are evidence-based and appropriate to actual conditions.